Home > Press > Needle-free vaccine technology a step closer to clinical trials
 |
| Professor Kendall with the Nanopatch |
Abstract:
Researchers at The University of Queensland believe they are a step closer to ridding the world of vaccinations with needles and syringes.
Needle-free vaccine technology a step closer to clinical trials
Brisbane | Posted on October 26th, 2010Professor Mark Kendall's team from the Australian Institute for Bioengineering and Nanotechnology (AIBN) has won a major award for their work on the needle-free vaccination delivery device Nanopatch.
As a consequence of winning the 2010 Translational Research Excellence Commercialisation Award, Professor Kendall will meet senior executives from global pharmaceutical company Merck Sharp and Dohme in the US.
The company will also pay up to $10,000 for Professor Kendall to attend the Bio 2011 convention in Washington DC.
Professor Kendall said winning the award was a "great shot in the arm" for his research team, providing both a pat on the back and a chance to move the technology forward.
"This is important, as it is a step towards partnering our Nanopatch with one of the world's leading vaccine companies," he said.
"Our ambition is for Nanopatch to be taken from the current stage of animal model success through the clinical trials, and on to the market as a next-generation vaccine delivery device, potentially displacing the needle and syringe.
"This progression requires commercialisation and partnership with the right players. This award is an important step along this pathway."
Nanopatch has been shown in trials to provide a protective immunisation in mice, with less than a hundredth of the dosage used compared to needle and syringe.
A part of the appeal of the Nanopatch is that it is painless, needle-free and is a potential solution for those with needle phobia.
Because the vaccine is formulated in dry form, it is also thermostable, removing the need for refrigeration.
Nanopatch is smaller than a postage stamp and is dissolvable, eliminating the possibility of needle-stick injury.
"When compared to needle and syringe immunisations - with all the associated costs - the Nanopatch is cheap to produce," Professor Kendall said.
"It is easy to imagine a situation in which a government might provide vaccinations for a pandemic such as swine flu to be collected from a chemist or sent in the mail."
Professor Kendall said the work had been in progress for five years and his team hoped to start clinical trials soon.
His research team has also been listed among the finalists in the Australian Museum Eureka Prizes and the UQ Business School's national Enterprize Business Plan Competition.
####
For more information, please click here
Contacts:
Professor Mark Kendall
3346 4203, 0431 162 391
Erik de Wit
07 3346 3962
Copyright © University of Queensland
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
| Related News Press |
News and information
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Products
Spectradyne Partners with Particle Technology Labs for Measurement Services December 6th, 2018
Mode-Changing MEMS Accelerometer from STMicroelectronics Combines High Measurement Resolution and Ultra-Low Power for Industrial Applications November 7th, 2018
Fat-Repellent Nanolayers Can Make Oven Cleaning Easier October 17th, 2018
Aculon, Inc. Enters into Strategic Partnership Agreement with Henkel Corporation to Supply Key Mobile Device Manufacturers with NanoProof® PCB Waterproof Technology October 17th, 2018
Possible Futures
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
With VECSELs towards the quantum internet Fraunhofer: IAF achieves record output power with VECSEL for quantum frequency converters April 5th, 2024
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Chemical reactions can scramble quantum information as well as black holes April 5th, 2024
Nanobiotechnology
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||